Innocan Pharma Corp. buy Indyro
Start price
15.09.21
/
80%
€0.70
Target price
15.09.22
€2.00
Performance (%)
-41.34%
End price
17.05.22
€0.41
Summary
This prediction ended on 17.05.22 with a price of €0.41. The BUY prediction by Indyro for Innocan Pharma Corp. performed very badly with a performance of -41.34%. Indyro has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innocan Pharma Corp. | - | - | - | - |
| iShares Core DAX® | -1,74 % | 5,67 % | 7,84 % | 50,71 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % | 36,61 % | 102,82 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % | 45,65 % | 64,80 % |
| iShares S&P 500 | 0,97 % | 7,24 % | 26,97 % | 70,25 % |
Comments by Indyro for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy Innocan Pharma Corp.